tert-Butyl 4-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidine-1-carboxylate

Catalog No. :
ACBLDW598
CAS No. :
609767-43-3
Molecular Formula :
C25H28ClFN4O4
Molecular Weight :
502.97

IUPAC Name:tert-butyl 4-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidine-1-carboxylate

tert-Butyl 4-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidine-1-carboxylate
Molecular FormulaC25H28ClFN4O4
Molecular Weight502.97
SMILESO=C(N1CCC(OC2=CC3=C(NC4=CC=C(F)C(Cl)=C4)N=CN=C3C=C2OC)CC1)OC(C)(C)C
InChI KeyLLTCDTSMNWDXIP-UHFFFAOYSA-N
Synonym6-[(1-tert-butoxycarbonylpiperidin-4-yl)oxy]-4-(3-chloro-4-fluoroanilino)-7-methoxyquinazoline;1-Piperidinecarboxylic acid, 4-[[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-, 1,1-dimethylethyl ester
CAS No.609767-43-3

Synthetic Route by SureRoute

1. ACBLDW598 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGETH780 route compound structure diagram
    ACGETH780184475-71-6 In Stock
  4. Then
  5. ACBLDW598 route product structure diagram
    ACBLDW598609767-43-3
Inquiry

2. ACBLDW598 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACBLDW598 route product structure diagram
    ACBLDW598609767-43-3
Inquiry

Comments (0)